Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4458338
Max Phase: Preclinical
Molecular Formula: C41H46N8O8
Molecular Weight: 778.87
Molecule Type: Unknown
Associated Items:
ID: ALA4458338
Max Phase: Preclinical
Molecular Formula: C41H46N8O8
Molecular Weight: 778.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCN(Cc1ccc(C(=O)OC)cc1)C(=O)Nc1ccc(OCCCCCn2cc(CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)nn2)cc1
Standard InChI: InChI=1S/C41H46N8O8/c1-3-4-21-47(25-27-11-13-28(14-12-27)40(54)56-2)41(55)43-29-15-17-31(18-16-29)57-23-7-5-6-22-48-26-30(45-46-48)24-42-33-10-8-9-32-36(33)39(53)49(38(32)52)34-19-20-35(50)44-37(34)51/h8-18,26,34,42H,3-7,19-25H2,1-2H3,(H,43,55)(H,44,50,51)
Standard InChI Key: AEELVLOYVCNYOX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 778.87 | Molecular Weight (Monoisotopic): 778.3439 | AlogP: 5.16 | #Rotatable Bonds: 18 |
Polar Surface Area: 194.16 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 0.59 | CX LogP: 5.06 | CX LogD: 5.06 |
Aromatic Rings: 4 | Heavy Atoms: 57 | QED Weighted: 0.07 | Np Likeness Score: -1.26 |
1. Wu H, Yang K, Zhang Z, Leisten ED, Li Z, Xie H, Liu J, Smith KA, Novakova Z, Barinka C, Tang W.. (2019) Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity., 62 (15): [PMID:31271281] [10.1021/acs.jmedchem.9b00516] |
Source(1):